Slawek J - Search Results

1

Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.

Slawek J, Bogucki A, Reclawowicz D. Slawek J, et al. Neurol Sci. 2005 Apr;26(1):32-9. doi: 10.1007/s10072-005-0379-8. Neurol Sci. 2005. PMID: 15877185 Clinical Trial.

2

Side effects of botulinum toxin injection for benign anal disorders.

Madaliński MH, Sławek J, Duzyński W, Zbytek B, Jagiełło K, Adrich Z, Kryszewski A. Madaliński MH, et al. Among authors: slawek j. Eur J Gastroenterol Hepatol. 2002 Aug;14(8):853-6. doi: 10.1097/00042737-200208000-00007. Eur J Gastroenterol Hepatol. 2002. PMID: 12172405

3

Functional improvement in cerebral palsy patients treated with botulinum toxin A injections - preliminary results.

Sławek J, Klimont L. Sławek J, et al. Eur J Neurol. 2003 May;10(3):313-7. doi: 10.1046/j.1468-1331.2003.00582.x. Eur J Neurol. 2003. PMID: 12752407 Clinical Trial.

4

[Dopa-responsive dystonia (Segawa variant): clinical analysis of 7 cases with delayed diagnosis].

Sławek J, Friedman A, Bogucki A, Budrewicz S, Banach M. Sławek J, et al. Neurol Neurochir Pol. 2003;37 Suppl 5:117-26. Neurol Neurochir Pol. 2003. PMID: 15098338 Polish.

5

[The central action of botulinum toxin type A assessed by brain auditory and somatosensory evoked potentials].

Sławek J, Recławowicz D. Sławek J, et al. Neurol Neurochir Pol. 2004 Mar-Apr;38(2):93-9. Neurol Neurochir Pol. 2004. PMID: 15307601 Clinical Trial. Polish.

6

[Botulinum toxin type A in the management of spasticity in adults: recommendations of an interdisciplinary group of experts].

Sławek J, Bogucki A, Banach M, Członkowska A, Friedman A, Krawczyk M, Kwolek A, Opara J, Ochudło S, Zaborski J. Sławek J, et al. Neurol Neurochir Pol. 2004 Nov-Dec;38(6):443-5. Neurol Neurochir Pol. 2004. PMID: 15654667 Polish. No abstract available.

7

[Motor cortex stimulation in the central pain syndrome].

Sławek J, Recławowicz D, Zieliński P, Słoniewski P, Nguyen JP. Sławek J, et al. Neurol Neurochir Pol. 2005 May-Jun;39(3):237-40; discussion 241. Neurol Neurochir Pol. 2005. PMID: 15981164 Polish.

8

[Frequency of side effects after botulinum toxin A injections in neurology, rehabilitation and gastroenterology].

Sławek J, Madaliński MH, Maciag-Tymecka I, Duzyński W. Sławek J, et al. Pol Merkur Lekarski. 2005 Mar;18(105):298-302. Pol Merkur Lekarski. 2005. PMID: 15997637 Polish.

9

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.

Slawek J, Friedman A, Potulska A, Krystkowiak P, Gervais C, Banach M, Ochudlo S, Budrewicz S, Reclawowicz D, Rynkowski M, Opala G. Slawek J, et al. Funct Neurol. 2007 Apr-Jun;22(2):95-100. Funct Neurol. 2007. PMID: 17637212

10

Phenotype of the DYT1 mutation in the TOR1A gene in a Polish population of patients with dystonia. A preliminary report.

Gajos A, Piaskowski S, Sławek J, Ochudło S, Opala G, Łobińska A, Honczarenko K, Budrewicz S, Koszewicz M, Pełszyńska B, Liberski PP, Bogucki A. Gajos A, et al. Among authors: slawek j. Neurol Neurochir Pol. 2007 Nov-Dec;41(6):487-94. Neurol Neurochir Pol. 2007. PMID: 18224570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters